Intercept Pharmaceuticals, Inc.

MORGAN STANLEY

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/15/2023

Shares

576,774

Value ($000)

10,693

Weight

0.0%

2013 Q4 - 2023 Q3 (18 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/15/2023	10,693	0.0%	576,774	9/30/2023
2023 Q2	8/14/2023	1,569	0.0%	141,902	6/30/2023
2023 Q1	5/15/2023	4,939	0.0%	367,781	3/31/2023
2022 Q4	2/14/2023	9,554	0.0%	772,380	12/31/2022
2022 Q3	11/14/2022	12,527	0.0%	897,973	9/30/2022
2022 Q2	10/27/2022	14,655	0.0%	1,061,169	6/30/2022
2022 Q1	10/27/2022	9,217	0.0%	566,492	3/31/2022
2021 Q4	2/14/2022	3,160	0.0%	193,965	12/31/2021
2021 Q3	11/15/2021	2,563	0.0%	172,676	9/30/2021
2021 Q2	8/23/2021	11,480	0.0%	574,811	6/30/2021
2021 Q1	5/17/2021	3,709	0.0%	160,721	3/31/2021
2020 Q4	2/16/2021	7,521	0.0%	304,497	12/31/2020
2020 Q3	11/13/2020	2,381	0.0%	57,432	9/30/2020
2020 Q2	8/14/2020	2,676	0.0%	55,869	6/30/2020
2020 Q1	5/26/2020	4,003	0.0%	63,571	3/31/2020
2019 Q4	2/14/2020	8,942	0.0%	72,156	12/31/2019
2014 Q1	5/13/2014	27,191	0.0%	82,449	3/31/2014
2013 Q4	2/13/2014	75	0.0%	1,098	12/31/2013